doi: 10.1017/S000711451500166X
The growing popularity of GLP-1 receptor agonists, especially semaglutide (Ozempic, Wegovy), has been accompanied by considerable social media attention and discussion, from which thorough analyses of user-generated data have emerged highlighting reductions in alcohol motivation, decreased drinking behavior, and altered subjective responses to alcohol (Arillotta et al
and B.K.K
Functional decline is accelerated in skeletal muscle and peripheral nerves due to advanced glycation end-product deposition, ectopic lipid accumulation, and impaired glucose uptake
Improved Quality of Life: By effectively managing blood sugar levels and promoting weight loss, Semaglutide can significantly enhance the overall quality of life for patients
Clinical trial data with orforglipron have shown no signal for thyroid C-cell pathology or MTC